Neovascular Glaucoma Treatment With Extraction of Anterior Chamber Fibrovascular Tissue
Open Access
- 1 August 2013
- journal article
- surgical technique
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 131 (8) , 1083-1085
Abstract
The use of antibody to vascular endothelial growth factor to treat neovascular glaucoma yields good anatomic results in most cases. However, this type of glaucoma can cause angle closure with decompensation of intraocular pressure secondary to fibrovascular tissue contraction in the anterior chamber. Our surgical technique treats the cause by removing the anterior chamber fibrous complex after administration of antibody to vascular endothelial growth factor, thus restoring the chamber angle.Keywords
This publication has 11 references indexed in Scilit:
- Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucomaClinical Ophthalmology, 2011
- Medical and Surgical Treatment of Neovascular GlaucomaInternational Ophthalmology Clinics, 2011
- Angiographic Changes in Iris and Iridocorneal Angle Neovascularization After Intravitreal Bevacizumab InjectionArchives of Ophthalmology (1950), 2010
- Role of Intravitreal Bevacizumab in Neovascular GlaucomaJournal of Ocular Pharmacology and Therapeutics, 2007
- Bevacizumab (Avastin) for the treatment of neovascular glaucomaClinical & Experimental Ophthalmology, 2007
- Intravitreal Bevacizumab (Avastin®) in the Treatment of Neovascular GlaucomaAmerican Journal of Ophthalmology, 2006
- REGRESSION OF NEOVASCULAR IRIS VESSELS BY INTRAVITREAL INJECTION OF BEVACIZUMABRetina, 2006
- USE OF INTRAVITREAL BEVACIZUMAB AS A PREOPERATIVE ADJUNCT FOR TRACTIONAL RETINAL DETACHMENT REPAIR IN SEVERE PROLIFERATIVE DIABETIC RETINOPATHYRetina, 2006
- Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma.British Journal of Ophthalmology, 1996
- Neovascular Glaucoma Complicating Carotid-Cavernous FistulaArchives of Ophthalmology (1950), 1963